February 18, 2019
Shire’s stand-alone product sales grew 3.9% year on year to US$15 billion in 2018, Takeda Pharmaceutical, which acquired the Dublin company last month, said on February 15. Product sales in the hematology franchise, which includes hemophilia treatments vying with Roche/Chugai...read more